Rigetti Computing, Inc. Common Stock
RGTI
$19.69
-9.53%
Rigetti Computing, Inc. is a pure-play quantum computing company that builds superconducting quantum computers and processors, selling systems ranging from 9 to 108 qubits and offering access via its Rigetti Quantum Cloud Services platform. The company operates as a speculative, early-stage player in the nascent but strategically critical quantum hardware and services industry. The current investor narrative is dominated by a massive $2 billion U.S. government funding initiative for quantum technologies, which has directly benefited Rigetti with a grant of up to $100 million, fueling a speculative rally as investors debate whether this lifeline validates its long-term potential or merely extends its cash-burning runway in a highly competitive and capital-intensive field.…
RGTI
Rigetti Computing, Inc. Common Stock
$19.69
Related headlines
Investment Opinion: Should I buy RGTI Today?
Rating & Thesis: Hold. RGTI is a purely speculative bet on quantum computing commercialization, where recent government funding has provided a crucial lifeline but does not yet justify the extreme valuation for risk-averse investors. The bullish analyst consensus is counterbalanced by a complete lack of fundamental earnings support.
Supporting Evidence: The stock trades at a trailing PS ratio of 968x, an astronomical premium that prices in decades of future growth. Revenue of $1.87 million in Q4 2025 actually declined 18% YoY, showing no commercial traction. While gross margin improved to 34.9% from negative, the company destroyed shareholder value with an ROE of -39.6% and burned -$77.2 million in TTM free cash flow. The government grant is a positive catalyst, but it does not change the underlying financial metrics. There is no clear analyst target price for upside calculation, underscoring the extreme uncertainty.
Risks & Conditions: The two biggest risks are the valuation collapsing if revenue growth fails to accelerate, and the cash burn exhausting the new funding within 15-18 months. This Hold rating would upgrade to a speculative Buy only if the company demonstrates sustained quarterly revenue growth above 50% YoY or announces a major commercial partnership. It would downgrade to a Sell if quarterly cash burn exceeds $25 million or if the stock breaks below its recent low of $13.32. Relative to any rational benchmark, the stock is dramatically overvalued, but it may remain so as long as the quantum narrative persists.
Sign up to view all
RGTI 12-Month Price Forecast
RGTI is a binary, narrative-driven investment where the recent government funding has reset the timeline but not the fundamental risk/reward equation. The neutral stance reflects the offsetting forces of a powerful catalyst against an extreme valuation and absent earnings. Confidence is medium because the company's fate is largely dependent on external factors (competitive landscape, additional funding) and technological progress that are difficult to model. The stance would upgrade to bullish on evidence of sustained revenue acceleration above 50% QoQ or a breakthrough partnership. It would downgrade to bearish if the next two quarters show no revenue growth or if cash burn exceeds $25M per quarter.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Rigetti Computing, Inc. Common Stock's 12-month outlook, with a consensus price target around $25.60 and implied upside of +30.0% versus the current price.
Average Target
$25.60
3 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
3
covering this stock
Price Range
$16 - $26
Analyst target range
Analyst coverage is limited with only 3 analysts providing estimates, and institutional rating data shows a pattern of recent 'Buy' or 'Outperform' actions from firms like Benchmark, Rosenblatt, and Mizuho, with B. Riley Securities upgrading from Neutral to Buy in January 2026. The consensus recommendation is bullish, but the lack of a published average target price in the data implies insufficient consensus for a precise upside calculation; the wide range in revenue estimates for the upcoming period, from a low of $172.9 million to a high of $276.1 million, underscores the extreme uncertainty and modeling challenges for this pre-revenue company. The high target scenario likely assumes successful commercialization and market leadership fueled by government contracts, while the low scenario prices in continued cash burn, technological hurdles, and competitive failure. The limited coverage and high uncertainty are typical for a small-cap, pre-commercial technology stock, leading to higher volatility and less efficient price discovery, making the stock suitable only for speculative, risk-tolerant investors.
Bulls vs Bears: RGTI Investment Factors
The investment debate for RGTI is a classic battle between speculative potential and financial reality. The bull case is currently stronger on momentum and sentiment, driven overwhelmingly by the transformative $100 million government grant that provides a lifeline and validation. However, the bear case is grounded in far more concrete and severe fundamental weaknesses: an extreme 968x PS valuation, minimal and declining revenue, and aggressive cash burn. The single most important tension is whether the government funding and improved gross margins mark the beginning of a credible path to commercialization that can justify the speculative premium, or if they merely extend a cash-burning runway in a race the company may ultimately lose to better-funded or more advanced competitors.
Bullish
- Massive Government Funding Catalyst: The $100 million U.S. government grant provides a crucial, non-dilutive cash infusion, validating Rigetti's strategic role in the national quantum race. This funding directly addresses the company's cash burn, extending its runway and reducing near-term financing risk.
- Strong Technical Momentum & Recovery: The stock has surged 32.2% over the past month and 104.4% over the past year, dramatically outperforming the S&P 500. This explosive rally, including a 30% single-day surge on May 22nd, signals a potential trend reversal from deeply oversold levels.
- Robust Balance Sheet & Liquidity: With a current ratio of 37.4 and a debt-to-equity ratio of 0.013, the company has exceptional liquidity and virtually no financial leverage. This strong financial position provides a buffer to fund aggressive R&D without immediate solvency concerns.
- Analyst Sentiment Turning Bullish: Recent analyst actions include upgrades from firms like B. Riley Securities (Neutral to Buy), reflecting growing institutional confidence post-government funding. The consensus recommendation is bullish, though coverage remains limited to only 3 analysts.
Bearish
- Extreme Valuation with No Earnings: The stock trades at an astronomical trailing Price-to-Sales (PS) ratio of 968x, reflecting a speculative premium disconnected from current financial reality. With negative net income and EBITDA, the valuation is entirely dependent on distant future commercialization success.
- Minimal & Declining Revenue: Q4 2025 revenue was just $1.87 million, representing an 18% year-over-year contraction. Revenue has stagnated in the $1-3 million range, confirming the company is in a pre-commercial phase with no meaningful sales traction.
- Aggressive Cash Burn & Value Destruction: The company burned $19.5 million in free cash flow in Q4 2025 and -$77.2 million over the trailing twelve months. This is coupled with a Return on Equity (ROE) of -39.6%, indicating significant shareholder value destruction as capital is consumed.
- Intense Competitive & Sector Risk: Recent news highlights the IPO of well-capitalized competitor Quantinuum, which could either lift the sector or cannibalize existing players. The success of peers like IonQ, which reported record revenue and profitability, increases pressure on Rigetti to demonstrate similar progress.
RGTI Technical Analysis
The stock is in a volatile recovery phase within a long-term downtrend, having gained 104.4% over the past year but still trading down 14.1% over the last six months. With a current price of $24.16, it sits approximately 24% above its 52-week low of $10.3 and 58% below its 52-week high of $58.15, indicating it is recovering from deeply oversold levels but remains far from previous highs, suggesting significant technical damage and a long road to full recovery. Recent momentum is exceptionally strong and diverging from the longer-term weakness, with the stock up 32.2% over the past month and 42.0% over the past three months, far outpacing the S&P 500's gains of 4.6% and 12.6%, respectively; this explosive short-term rally, highlighted by a 30% single-day surge on May 22nd, is primarily driven by the government funding catalyst and signals a potential trend reversal if the momentum can be sustained. Key technical levels are the 52-week low of $10.30 as critical support and the 52-week high of $58.15 as major resistance; a sustained breakout above the recent high near $27 would signal continued bullish momentum, while a breakdown below $10.30 would indicate a failure of the recovery. The stock's beta of 1.801 confirms it is approximately 80% more volatile than the broader market, which is critical for risk management given its propensity for large swings on sector news.
Beta
1.90
1.90x market volatility
Max Drawdown
-77.1%
Largest decline past year
52-Week Range
$10-$58
Price range past year
Annual Return
+73.9%
Cumulative gain past year
| Period | RGTI Return | S&P 500 |
|---|---|---|
| 1m | +4.0% | -0.1% |
| 3m | +16.2% | +9.0% |
| 6m | -26.7% | +7.0% |
| 1y | +73.9% | +22.9% |
| ytd | -16.6% | +8.1% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
RGTI Fundamental Analysis
Revenue is minimal and declining, with Q4 2025 revenue of just $1.87 million representing an 18% year-over-year contraction, and the multi-quarter trend shows revenue stagnating in the $1-3 million range, indicating the company is in a pre-commercial, R&D-intensive phase with no meaningful sales traction yet. The company is deeply unprofitable with a net income of -$18.2 million in Q4 2025 and a gross margin of 34.9%, though this represents a significant improvement from the negative gross margin of -0.9% reported in the valuation data; losses are substantial but the improvement in gross margin from deeply negative to positive suggests progress on cost control and product viability. The balance sheet shows a strong current ratio of 37.4 and minimal debt with a debt-to-equity ratio of 0.013, indicating high liquidity and low financial leverage, but it is burning cash aggressively with free cash flow of -$19.5 million in Q4 2025 and trailing twelve-month free cash flow of -$77.2 million; the negative return on equity of -39.6% underscores the destruction of shareholder value as the company invests heavily in R&D without generating returns.
Quarterly Revenue
$1868000.0B
2025-12
Revenue YoY Growth
-0.17%
YoY Comparison
Gross Margin
+0.34%
Latest Quarter
Free Cash Flow
$-77219000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is RGTI Overvalued?
Given the company's negative net income and EBITDA, the primary valuation metric is the Price-to-Sales (PS) ratio. The trailing PS ratio is an astronomical 968.0x, while the forward PS ratio is not explicitly provided but implied to be high given minimal revenue estimates; this extreme multiple reflects the market's speculative valuation of future potential rather than current financial reality. Comparing to industry averages is challenging due to the niche nature of quantum computing, but such a PS ratio represents an extreme premium to any traditional hardware or tech sector, justified only by the belief in a transformative, winner-take-all market opportunity that is still years away from materializing. Historically, the stock's own PS ratio has been wildly volatile, ranging from 14.7x in late 2022 to over 3,673x in Q4 2025; the current 968x PS is below the recent peak but remains near the very top of its multi-year range, indicating the market is still pricing in highly optimistic expectations despite the significant price decline from all-time highs.
PE
-31.7x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range -94x~13x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-89.2x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks are severe and center on the company's pre-commercial status. Revenue is minimal at $1.87 million and declining 18% YoY, indicating no product-market fit. The company is burning cash aggressively, with TTM free cash flow of -$77.2 million; the $100 million grant extends the runway but does not solve the fundamental lack of revenue. Gross margin, while improved to 34.9%, is volatile and operating from a deeply negative base, highlighting ongoing cost and pricing challenges. The extreme valuation (968x PS) creates massive downside risk if growth expectations are delayed or fail to materialize.
Market & Competitive Risks are heightened by the nascent and winner-take-all nature of the quantum computing sector. The recent IPO of Quantinuum introduces a new, well-capitalized competitor that could consolidate market share. Peer IonQ's reported profitability and record revenue set a benchmark that Rigetti has not met, increasing competitive pressure. The stock's beta of 1.801 confirms it is highly sensitive to sector news and broader market sentiment toward speculative tech. As a pure-play quantum stock, it faces sector rotation risk if investor appetite for pre-revenue, capital-intensive stories wanes.
Worst-Case Scenario involves a failure to achieve technological milestones or commercial adoption, leading to the government funding being viewed as a last lifeline rather than a springboard. In this scenario, cash burn continues unabated, revenue fails to inflect, and the company faces dilution or restructuring. The realistic downside is severe: a return to the 52-week low of $10.30, which represents a -57% decline from the current price of $24.16. The historical max drawdown of -77.1% provides a precedent for such catastrophic losses, which could be triggered by a failed product launch, a key competitor breakthrough, or a broader risk-off environment for speculative assets.
FAQ
The key risks are: 1) Valuation & Financial Risk: The extreme 968x PS ratio creates massive downside if growth disappoints, coupled with aggressive cash burn (-$77.2M TTM) and no profitability. 2) Commercialization Risk: Revenue is minimal ($1.87M) and declining, with no clear path to significant sales. 3) Competitive Risk: New, well-funded entrants like Quantinuum and successful peers like IonQ threaten Rigetti's market position. 4) Technical & Volatility Risk: The stock is 80% more volatile than the market (Beta 1.8) and remains 58% below its high, indicating high price risk. The financial and commercialization risks are the most severe, as they threaten the company's very existence.
The 12-month forecast for RGTI is a wide range of outcomes due to its binary nature. The base case (50% probability) sees the stock trading between $18 and $28 as the initial funding rally cools and the company shows slow progress. The bull case (25% probability) targets $45 to $58 if commercialization accelerates dramatically. The bear case (25% probability) warns of a drop to $10 to $15 if execution falters and sentiment sours. The base case is most likely, assuming the government grant funds continued R&D but does not trigger an immediate revenue inflection. The forecast is exceptionally uncertain due to limited analyst coverage and the pre-revenue business model.
RGTI is dramatically overvalued by any conventional financial metric. With a trailing Price-to-Sales ratio of 968x, it is valued at nearly 1000 times its annual revenue, which is an extreme premium even for high-growth tech. Compared to its own history, the PS ratio remains near the top of its multi-year range. The valuation implies the market expects Rigetti to achieve rapid, massive revenue growth and eventual market leadership in quantum computing—a scenario that is years away and highly uncertain. There is no rational 'undervaluation' argument based on current financials; the price is purely a bet on future potential.
RGTI is not a 'good buy' for most investors seeking stability, income, or growth supported by fundamentals. It is a highly speculative purchase suitable only for investors who understand and can tolerate extreme risk. The recent $100 million government grant is a positive catalyst, but the stock trades at a 968x Price-to-Sales ratio with declining revenue and significant cash burn. For a venture-style investor allocating a small portion of capital to a potential quantum computing winner, it could be a tactical buy. For the average retail investor, the risk of a -57% drawdown to its 52-week low outweighs the uncertain upside.
RGTI is unsuitable for short-term trading for all but the most sophisticated and risk-tolerant traders due to its extreme volatility (Beta 1.8) and sensitivity to news headlines. As a long-term investment, it is only appropriate for investors with a 5-10 year horizon who are betting on quantum computing becoming a viable commercial market and Rigetti being a winner. The company has no dividends, negative earnings, and high cash burn, meaning there is no income or stability for short-term holders. A minimum holding period cannot be rationally defined; it is a capital commitment to see through multiple years of development and potential dilution before any fundamental payoff.